Indeed, this finding is consistent with previous studies showing that the landscape of cancer coagulome expression varies significantly among different cancer types, with varying levels of tissue factor (TF), podoplanin (PDPN), inflammatory mediators, leukocytosis, and platelet counts [21–23]. This evidence concerns the gene PDPN and cancer.